marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 05.12.2024
KalVista Pharmaceuticals Finanzdaten 2011-2024 | KALV
Jahresabschluß KalVista Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
248 M | 200 M | 347 M | 86.7 M | 33.1 M | 8.77 M | - | - | - | - | - |
Anteile |
19.1 M | 17.7 M | 15.1 M | 10.3 M | 4.65 M | 591 K | - | - | - | - | - |
Kurshistorie |
13.2 | 19 | 17.8 | 19.8 | 9.75 | 7.07 | 50.7 | - | - | - | - |
Nettogewinn |
-46.2 M | -29.1 M | -20.8 M | -15.8 M | -18.6 M | -11.4 M | -7.23 M | -13.4 M | -5.68 M | -2.05 M | - |
Umsatz |
- | 12.7 M | 16.1 M | 8.39 M | 1.5 M | 2.13 M | 1.8 M | 29 K | 415 K | 1.54 M | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-57.9 M | -40.5 M | -29.8 M | -18.7 M | -22.3 M | -15.2 M | -21 M | -11.7 M | -5.22 M | - | - |
Zinsaufwendungen |
9.93 M | 9.83 M | 7.68 M | 4.39 M | 2.33 M | 2.03 M | 1.19 M | 1.08 M | 405 K | - | - |
EBITDA |
-57.4 M | -40 M | -29.4 M | -18.5 M | -22.3 M | -15.1 M | -8.05 M | -11.6 M | -5.19 M | -1.8 M | - |
Betriebsaufwand |
57.9 M | 53.2 M | 45.9 M | 27.1 M | 23.8 M | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
16.6 M | 13 M | 10.9 M | 8.86 M | 11.2 M | 2.65 M | 1.61 M | 3.41 M | 1.4 M | 1.41 M | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich KalVista Pharmaceuticals
| 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
46.7 M | 42.5 M | 34.7 M | 34.6 M | 34.4 M | 34.2 M | 28.3 M | 24.6 M | 24.6 M | 24.6 M | 18 M | 24.4 M | 24.4 M | 24.4 M | 17.8 M | 17.9 M | 17.9 M | 17.8 M | 17.2 M | 17.8 M | 17.8 M | 17.5 M | 10.8 M | 15.1 M | 15.1 M | 10.8 M | 7.66 M | 10 M | 10 M | 9.71 M | 631 K | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 22.6 M | 702 K | 691 K | 678 K | 618 K | 459 K | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-42.3 M | - | -29 M | -27.6 M | -25.3 M | - | -21.3 M | -22.3 M | -23 M | - | -10 M | -19.6 M | -35.8 M | -16.1 M | -9.29 M | -10.4 M | -10.4 M | -10.8 M | -3.96 M | -5.9 M | -5.9 M | -7.34 M | -5.23 M | -3.3 M | -3.3 M | -5.03 M | -7.64 M | -4.99 M | -4.99 M | -4.93 M | - | -2.38 M | -7.35 M | -6.61 M | -5.66 M | -4.99 M | -9.01 M | -5.18 M | -4.71 M | -4 M | -2.64 M | -2.02 M | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatz |
- | - | - | - | - | - | -21.3 M | -22.3 M | -23 M | 24.6 M | -22.5 M | -19.6 M | -16.1 M | - | 1.58 M | 8.87 M | - | 3.82 M | 3.89 M | 3.92 M | 3.92 M | 3.37 M | 2.33 M | 5.59 M | 5.59 M | 4.84 M | 248 K | 1.13 M | 1.13 M | 114 K | - | 197 K | 975 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-45.8 M | - | -33.2 M | -29.7 M | -29.1 M | - | -26.9 M | -25.9 M | -26.3 M | - | -12.7 M | -23.6 M | -43.1 M | - | -12.7 M | -12.8 M | -12.8 M | -14.4 M | -6.66 M | -9.29 M | -9.29 M | -9.56 M | -4.35 M | -4.89 M | -4.89 M | -7.01 M | -8.12 M | -5.94 M | -5.94 M | -5.45 M | -3.82 M | -2.4 M | -6.96 M | -6.53 M | - | -4.9 M | -5.67 M | -4.9 M | - | -3.57 M | -2.44 M | -1.86 M | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
2.12 M | - | 2.32 M | 2.62 M | 2.4 M | - | 4.31 M | 3.49 M | 3.55 M | - | 2.17 M | 3.94 M | 7.13 M | - | 2.92 M | 2.19 M | 2.19 M | 2.93 M | 1.73 M | 2.32 M | 2.32 M | 2.09 M | 985 K | 1.62 M | 1.62 M | 1.82 M | 661 K | 867 K | 867 K | 555 K | 546 K | 1 K | 406 K | 88 K | - | 95 K | 169 K | 836 K | - | 357 K | 83 K | 80 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | -28.9 M | - | -26.9 M | -25.9 M | -26.2 M | - | -12.7 M | -23.2 M | -42.9 M | - | -12.7 M | -12.4 M | -12.5 M | -14.3 M | -6.66 M | -9.03 M | -9.04 M | -9.44 M | -4.35 M | -4.76 M | -4.74 M | -6.96 M | -8.12 M | -5.91 M | -5.86 M | -5.42 M | -3.82 M | -2.38 M | -6.96 M | -6.49 M | - | -4.8 M | -5.6 M | -4.87 M | - | -3.53 M | -2.42 M | -1.85 M | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
45.8 M | - | 33.2 M | 29.7 M | 29.1 M | - | 26.9 M | 25.9 M | 26.3 M | - | 12.7 M | 23.6 M | 43.1 M | - | 14.3 M | 12.8 M | 12.8 M | 14.4 M | 10.6 M | 13.2 M | 13.2 M | 12.9 M | 6.68 M | 10.5 M | 10.5 M | 10.7 M | 8.36 M | 7.06 M | 7.06 M | 5.55 M | - | 2.41 M | 6.97 M | 6.54 M | 5.58 M | 4.91 M | 5.67 M | 4.91 M | 3.82 M | 3.58 M | 2.44 M | 1.86 M | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
29.2 M | - | 10.6 M | 10.7 M | 9.79 M | - | 6.88 M | 7.81 M | 8.13 M | - | 3.56 M | 6.06 M | 11.9 M | - | 3.07 M | 3.63 M | 3.63 M | 3.28 M | 2.9 M | 3.42 M | 3.42 M | 3.25 M | 2.13 M | 2.61 M | 2.61 M | 2.37 M | 5.03 M | 2.7 M | 2.7 M | 2.07 M | 541 K | 2.08 M | 2.6 M | 1.54 M | - | 1.37 M | 1.17 M | 1.01 M | - | 1.49 M | 691 K | 437 K | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung